Literature DB >> 29579402

Biodegradable Polymeric Nanoparticles for Therapeutic Cancer Treatments.

Johan Karlsson1,2, Hannah J Vaughan1, Jordan J Green1,3.   

Abstract

Polymeric nanoparticles have tremendous potential to improve the efficacy of therapeutic cancer treatments by facilitating targeted delivery to a desired site. The physical and chemical properties of polymers can be tuned to accomplish delivery across the multiple biological barriers required to reach diverse subsets of cells. The use of biodegradable polymers as nanocarriers is especially attractive, as these materials can be designed to break down in physiological conditions and engineered to exhibit triggered functionality when at a particular location or activated by an external source. We present how biodegradable polymers can be engineered as drug delivery systems to target the tumor microenvironment in multiple ways. These nanomedicines can target cancer cells directly, the blood vessels that supply the nutrients and oxygen that support tumor growth, and immune cells to promote anticancer immunotherapy.

Entities:  

Keywords:  angiogenesis; drug delivery; immunotherapy; nanocarrier; stimuli-responsive materials; targeted delivery

Mesh:

Substances:

Year:  2018        PMID: 29579402      PMCID: PMC6215694          DOI: 10.1146/annurev-chembioeng-060817-084055

Source DB:  PubMed          Journal:  Annu Rev Chem Biomol Eng        ISSN: 1947-5438            Impact factor:   11.059


  151 in total

1.  Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration.

Authors:  Matthias Van Woensel; Nathalie Wauthoz; Rémi Rosière; Véronique Mathieu; Robert Kiss; Florence Lefranc; Brecht Steelant; Ellen Dilissen; Stefaan W Van Gool; Thomas Mathivet; Holger Gerhardt; Karim Amighi; Steven De Vleeschouwer
Journal:  J Control Release       Date:  2016-02-21       Impact factor: 9.776

Review 2.  Chemokines and their role in tumor growth and metastasis.

Authors:  J M Wang; X Deng; W Gong; S Su
Journal:  J Immunol Methods       Date:  1998-11-01       Impact factor: 2.303

3.  Co-encapsulation of magnetic nanoparticles and doxorubicin into biodegradable microcarriers for deep tissue targeting by vascular MRI navigation.

Authors:  Pierre Pouponneau; Jean-Christophe Leroux; Gilles Soulez; Louis Gaboury; Sylvain Martel
Journal:  Biomaterials       Date:  2011-02-18       Impact factor: 12.479

4.  Stepwise pH-responsive nanoparticles containing charge-reversible pullulan-based shells and poly(β-amino ester)/poly(lactic-co-glycolic acid) cores as carriers of anticancer drugs for combination therapy on hepatocellular carcinoma.

Authors:  Cong Zhang; Tong An; Dan Wang; Guoyun Wan; Mingming Zhang; Hemei Wang; Sipei Zhang; Rongshan Li; Xiaoying Yang; Yinsong Wang
Journal:  J Control Release       Date:  2016-02-16       Impact factor: 9.776

5.  Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy.

Authors:  Jong-Ho Kim; Yoo-Shin Kim; Kyeongsoon Park; Eunah Kang; Seulki Lee; Hae Yun Nam; Kwangmeyung Kim; Jae Hyung Park; Dae Yoon Chi; Rang-Woon Park; In-San Kim; Kuiwon Choi; Ick Chan Kwon
Journal:  Biomaterials       Date:  2008-04       Impact factor: 12.479

6.  Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.

Authors:  M E R O'Brien; N Wigler; M Inbar; R Rosso; E Grischke; A Santoro; R Catane; D G Kieback; P Tomczak; S P Ackland; F Orlandi; L Mellars; L Alland; C Tendler
Journal:  Ann Oncol       Date:  2004-03       Impact factor: 32.976

7.  A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours.

Authors:  R Plummer; R H Wilson; H Calvert; A V Boddy; M Griffin; J Sludden; M J Tilby; M Eatock; D G Pearson; C J Ottley; Y Matsumura; K Kataoka; T Nishiya
Journal:  Br J Cancer       Date:  2011-02-01       Impact factor: 7.640

8.  Enhanced and selective delivery of enzyme therapy to 9L-glioma tumor via magnetic targeting of PEG-modified, β-glucosidase-conjugated iron oxide nanoparticles.

Authors:  Jie Zhou; Jian Zhang; Wenxi Gao
Journal:  Int J Nanomedicine       Date:  2014-06-10

9.  Polymeric nanoparticles for nonviral gene therapy extend brain tumor survival in vivo.

Authors:  Antonella Mangraviti; Stephany Yi Tzeng; Kristen Lynn Kozielski; Yuan Wang; Yike Jin; David Gullotti; Mariangela Pedone; Nitsa Buaron; Ann Liu; David R Wilson; Sarah K Hansen; Fausto J Rodriguez; Guo-Dong Gao; Francesco DiMeco; Henry Brem; Alessandro Olivi; Betty Tyler; Jordan J Green
Journal:  ACS Nano       Date:  2015-02-10       Impact factor: 15.881

Review 10.  Galectins and gliomas.

Authors:  Marie Le Mercier; Shannon Fortin; Véronique Mathieu; Robert Kiss; Florence Lefranc
Journal:  Brain Pathol       Date:  2009-04-07       Impact factor: 6.508

View more
  30 in total

Review 1.  Biomaterials for vaccine-based cancer immunotherapy.

Authors:  Rui Zhang; Margaret M Billingsley; Michael J Mitchell
Journal:  J Control Release       Date:  2018-10-09       Impact factor: 9.776

Review 2.  Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy.

Authors:  Alvin J Mukalel; Rachel S Riley; Rui Zhang; Michael J Mitchell
Journal:  Cancer Lett       Date:  2019-05-14       Impact factor: 8.679

Review 3.  Poly(beta-amino ester)s as gene delivery vehicles: challenges and opportunities.

Authors:  Johan Karlsson; Kelly R Rhodes; Jordan J Green; Stephany Y Tzeng
Journal:  Expert Opin Drug Deliv       Date:  2020-07-31       Impact factor: 6.648

4.  Polymeric nanoparticles for dual-targeted theranostic gene delivery to hepatocellular carcinoma.

Authors:  Hannah J Vaughan; Camila G Zamboni; Laboni F Hassan; Nicholas P Radant; Desmond Jacob; Ronnie C Mease; Il Minn; Stephany Y Tzeng; Kathleen L Gabrielson; Pranshu Bhardwaj; Xin Guo; David Francisco; Martin G Pomper; Jordan J Green
Journal:  Sci Adv       Date:  2022-07-20       Impact factor: 14.957

Review 5.  Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies.

Authors:  Johan Karlsson; Kathryn M Luly; Stephany Y Tzeng; Jordan J Green
Journal:  Adv Drug Deliv Rev       Date:  2021-10-27       Impact factor: 17.873

6.  Verteporfin-Loaded Anisotropic Poly(Beta-Amino Ester)-Based Micelles Demonstrate Brain Cancer-Selective Cytotoxicity and Enhanced Pharmacokinetics.

Authors:  James G Shamul; Sagar R Shah; Jayoung Kim; Paula Schiapparelli; Carla A Vazquez-Ramos; Ben J Lee; Kisha K Patel; Alyssa Shin; Alfredo Quinones-Hinojosa; Jordan J Green
Journal:  Int J Nanomedicine       Date:  2019-12-23

Review 7.  Novel approaches for vaccine development.

Authors:  Makda S Gebre; Luis A Brito; Lisa H Tostanoski; Darin K Edwards; Andrea Carfi; Dan H Barouch
Journal:  Cell       Date:  2021-03-18       Impact factor: 41.582

Review 8.  Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges.

Authors:  Weisen Zhang; Ami Mehta; Ziqiu Tong; Lars Esser; Nicolas H Voelcker
Journal:  Adv Sci (Weinh)       Date:  2021-03-07       Impact factor: 16.806

9.  pH and Reduction Dual-Responsive Bi-Drugs Conjugated Dextran Assemblies for Combination Chemotherapy and In Vitro Evaluation.

Authors:  Xiukun Xue; Yanjuan Wu; Xiao Xu; Ben Xu; Zhaowei Chen; Tianduo Li
Journal:  Polymers (Basel)       Date:  2021-05-08       Impact factor: 4.329

10.  Distribution of Gold Nanoparticles in the Anterior Chamber of the Eye after Intracameral Injection for Glaucoma Therapy.

Authors:  Tobias Sonntag; Franziska Froemel; W Daniel Stamer; Andreas Ohlmann; Rudolf Fuchshofer; Miriam Breunig
Journal:  Pharmaceutics       Date:  2021-06-17       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.